National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Cancer Genome Project
< Back to Main
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 27 : CGAP Helps Cancer Research in the Clinic: Differentiating Between Cancers with Similar Clinical Symptoms previousnext

Microarrays have recently been used to discover that what appeared to be a single type of lymphoma was actually a mixture of two cancer subtypes at the molecular level. CGAP cancer researchers then discovered that only one subtype gave the best overall response. New treatment strategies must be developed to improve response for all subtypes of cancer.

CGAP Helps Cancer Research in the Clinic: Differentiating Between Cancers with Similar Clinical Symptoms

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov